Treatment Resistant Depression clinical trials

Explore recruiting treatment resistant depression clinical trials.

Recruiting treatment resistant depression studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Treatment Resistant Depression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational study

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Nitrous Oxide in Resistant Depression in Elderly Subjects: A Randomized, Double-blind, Comparator Trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational study

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Advancing PRecise Interventions for resistant DEpression: rebalancing brain networks and investigating the trajectories of antidepressant effect with psilocybin and personalized neuromodulation (PRIDE)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, with Open Label Extension, in Patients with Treatment Resistant Depression

Poland, Spain, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Ketamine maintenance treatment for depression: A multicenter open-label randomized controlled trial

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment Resistant Depression trials by city

Treatment Resistant Depression in Toronto Treatment Resistant Depression in Vancouver Treatment Resistant Depression in Montreal Treatment Resistant Depression in Calgary Treatment Resistant Depression in Edmonton Treatment Resistant Depression in Ottawa Treatment Resistant Depression in Winnipeg Treatment Resistant Depression in Quebec City Treatment Resistant Depression in Hamilton Treatment Resistant Depression in Kitchener Treatment Resistant Depression in London Treatment Resistant Depression in Halifax Treatment Resistant Depression in New York Treatment Resistant Depression in Los Angeles Treatment Resistant Depression in Chicago Treatment Resistant Depression in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease